TheStreet upgraded shares of Paulson Capital Corp. (NASDAQ:PLCC) from a sell rating to a hold rating in a research note released on Thursday morning, American Banking Newsreports. “Paulson Capital (PLCC) has been upgraded by TheStreet Ratings from sell to hold. Paulson Capital Corp. (NASDAQ:PLCC) shares after opening at $1.19 moved to $1.49 on last trade day and at the end of the day closed at $1.20. Company price to sales ratio in past twelve months was calculated as 1.59 and price to cash ratio as 0.63. Paulson Capital Corp. (NASDAQ:PLCC) showed a positive weekly performance of 4.35%.
Marketo Inc (NASDAQ:MKTO)‘s stock had its “neutral” rating restated by stock analysts at UBS AG in a report issued on Friday, Analyst RN reports. They currently have a $32.00 price target on the stock. UBS AG’s price objective would indicate a potential upside of 21.03% from the company’s current price. Marketo Inc (NASDAQ:MKTO) shares fell -8.07% in last trading session and ended the day on $26.44. Marketo Inc (NASDAQ:MKTO) return on equity ratio is recorded as -67.70% and its return on assets is -30.00%.
3D Material Technologies (3DMT), a division of ARC Group Worldwide Inc (NASDAQ:ARCW), has launched an online quoting system for 3D printing on its website. ARC Group WorldWide Inc (NASDAQ:ARCW) shares moved down -12.24% in last trading session and was closed at $40.42 while trading in range of $38.64 – $45.31 year to date (YTD) performance is 62.59%.
In February, Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), a Woodcliff Lake-based pharmaceutical company that develops and sells in jectable versions of expiring patented drugs, closed its first day of public trading on the Nasdaq Stock Market at $12.60 a share. Since then, the share price has pulled back, and on Tuesday, Eagle’s shares fell 5 cents to $12. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) weekly performance is -10.73%. On last trading day company shares ended up $10.23. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) distance from 50-day simple moving average (SMA50) is -22.18%. Analysts mean target price for the company is $21.67.